| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Collagen alpha-1(I) chain|Alpha-1 type I collagen|COL1A1| |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
mouse COL1 (Collagen Type I) is a molecular target commonly studied in signal transduction, cancer, and immunology research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of COL1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of COL1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
COL1 (Collagen Type I) may also be referenced as Collagen alpha-1(I) chain, Alpha-1 type I collagen, and COL1A1 in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how COL1 relates to tumor microenvironment biology, cell proliferation and apoptosis, metastasis and invasion pathways, and angiogenesis and immune-oncology mechanisms in signal transduction, cancer, and immunology research.
- Interpreting shifts in COL1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
COL1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with signal transduction, cancer, and immunology studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Potentiating immunotherapy in “immune-cold” solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering
IF: 10.6 Journal: Cell Reports Medicine Author: School of Life Science, Beijing Institute of Technology, Beijing 100081, China. Cited Date: 2025-12-26
Effects of chitinase-1 inhibitor in obesity-induced and-aggravated asthma in a murine model
IF: 6.1 Journal: Life Sciences Author: Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea Cited Date: 2023-11-10
Prostaglandin F2α exacerbated dry eye by promoting lacrimal gland fibrosis progression through the activation of the RhoA/ROCKs signaling pathway
IF: 5.6 Journal: The Ocular Surface Author: Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, Eye Institute of Xiamen University, School of Medicine, Xiamen Unive Cited Date: 2025-07-25
lncRNA H19 promotes matrix mineralization through up-regulating IGF1 by sponging miR-185-5p in osteoblasts
IF: 3.485 Journal: BMC Molecular and Cell Biology Cited Date: 2019-11-12
Synthesis of active molecular chitosan with selective molecular weight and its potential to promote wound healing
IF: 2.8 Journal: Macromolecular Research Author: Department of Life Sciences, Gachon University, Seongnamdaero 1342, Seongnam-si, Gyeonggi-do, 461-701, Korea Cited Date: 2025-05-23
Assessment of Orlistat and Niclosamide Against Isoprenaline-induced Cardiac Fibrosis in Mouse Model
IF: Journal: Krishikosh Repository Author: DEEMED UNIVERSITY, ICAR-Indian Veterinary Research Institute, Izatnagar - 243 122 (U.P.), India Cited Date: 2024-08-16